Veenat 400mg, with its primary component Imatinib Mesylate, is primarily used in the treatment of specific cancers and other life-threatening conditions. It works by inhibiting the abnormal proteins responsible for the growth of cancer cells. This targeted therapy approach minimizes harm to healthy cells, reducing side effects commonly associated with traditional chemotherapy.